FDA recommends guidance Revision Over Dialysis System Tubing Concern
The Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe, uninterrupted renal replacement therapy in critical care settings.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.